Skip to main content
    T

    Tivic Health Systems Inc (TIVC)

    Official site

    MEDICAL DEVICES

    $0.53
    +0.02 (+4.05%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Tivic Health Systems Inc (TIVC) Financials: Revenue, Profit and Cash Flow

    Updated Dec 31, 2025. Financial statements from company filings, amounts in US dollars.

    Tivic Health Systems reported revenue of $382.00K for the fiscal year ended Dec 31, 2025, down 51.0% from the year before. That year, net income was -$8.88M with a net margin of -2324.1%, operating cash flow was -$7.00M and free cash flow was -$7.58M. The quarter ended Dec 31, 2025 had revenue of -$302.00K and net income of -$2.85M.

    Revenue and Margins

    Over the 6 years to Dec 2025, revenue fell from $420.00K, a compound annual decline of 1.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$382.00K-51.0%8.4%-2067.5%-2324.1%
    Dec 2024$780.00K-33.7%0.3%-725.8%-725.0%
    Dec 2023$1.18M-36.1%24.4%-701.1%-701.0%
    Dec 2022$1.84M+57.8%16.3%-548.8%-548.7%
    Dec 2021$1.17M+35.6%-11.1%-483.0%-728.5%
    Dec 2020$860.00K+104.8%-26.2%-372.6%-423.1%
    Dec 2019$420.00KN/A-68.8%-867.4%-987.6%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Dec 2025, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$382.00K$780.00K$1.18M$1.84M$1.17M$860.00K$420.00K
    Cost of revenue$350.00K$778.00K$889.00K$1.54M$1.29M$1.08M$709.00K
    Gross profit$32.00K$2.00K$287.00K$299.00K-$129.00K-$225.00K-$289.00K
    Research and development$3.13M$1.31M$1.66M$1.73M$878.00K$659.00K$990.00K
    Operating income-$7.90M-$5.66M-$8.24M-$10.10M-$5.63M-$3.20M-$3.64M
    Net income-$8.88M-$5.66M-$8.24M-$10.10M-$8.49M-$3.64M-$4.15M
    EBITDA-$7.84M-$5.31M-$8.06M-$9.92MN/AN/AN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Revenue-$302.00K$146.00K$86.00K$70.00K$180.00K$126.00K$140.00K$334.00K$357.00K$282.00K$161.00K$376.00K
    Gross profit$73.00K-$145.00K$54.00K$50.00K-$239.00K$44.00K$30.00K$167.00K$3.00K$108.00K$61.00K$113.00K
    Operating income-$1.98M-$2.48M-$1.93M-$1.51M-$1.54M-$1.43M-$1.21M-$1.48M-$2.24M-$1.76M-$2.13M-$2.12M
    Net income-$2.85M-$2.60M-$1.93M-$1.50M-$1.48M-$1.43M-$1.27M-$1.48M-$2.24M-$1.76M-$2.13M-$2.12M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded long-term debt of $6.45M by $6.19M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$31.61M$2.81M$5.16M$6.02M$15.04M$1.53M$3.02M
    Current assets$13.01M$2.64M$4.65M$4.72M$14.29M$1.50M$2.97M
    Cash and equivalents$12.64M$2.00M$3.40M$3.52M$12.97M$1.04M$2.31M
    Total liabilities$14.81M$272.00K$1.58M$2.39M$1.76M$2.71M$653.00K
    Short-term debtN/AN/A$193.00K$163.00K$163.00K$36.00K$1.00K
    Long-term debt$6.45MN/AN/AN/AN/A$1.43MN/A
    Shareholder equity$16.80M$2.54M$3.58M$3.63M$13.27M-$1.18M$2.37M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total assets$31.61M$6.23M$4.51M$3.78M$2.81M$3.39M$4.78M$3.29M$5.25M$7.01M$4.60M$7.10M
    Total liabilities$14.81M$638.00K$821.00K$741.00K$272.00K$560.00K$591.00K$1.13M$1.67M$1.24M$1.44M$1.90M
    Cash and equivalents$12.64M$3.45M$1.18M$669.00K$2.00M$2.19M$3.69M$1.67M$3.40M$5.17M$2.66M$5.17M
    Shareholder equity$16.80M$5.59M$3.69M$3.04M$2.54M$2.83M$4.19M$2.15M$3.58M$5.76M$3.16M$5.21M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$7.00M-$5.72M-$8.51M-$8.92M-$5.61M-$3.03M-$3.67M
    Capital expenditures$581.00K$0$118.00K$11.00K$0$0$31.00K
    Free cash flow-$7.58M-$5.72M-$8.63M-$8.93M-$5.61M-$3.03M-$3.70M
    Investing cash flow-$705.00KN/A-$118.00K-$11.00KN/AN/A-$31.00K
    Financing cash flow$18.35M$4.33M$8.51M-$528.00K$17.54M$1.76M$5.55M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Operating cash flow-$2.29M-$2.00M-$1.83M-$889.00K-$1.36M-$1.41M-$1.29M-$1.67M-$1.77M-$1.87M-$2.44M-$2.43M
    Capital expenditures$546.00K$10.00K$20.00K$526.00K$0$0$0$0$118.00K$0$24.00K$94.00K
    Free cash flow-$2.83M-$2.01M-$1.85M-$1.42M-$1.36M-$1.41M-$1.29M-$1.67M-$1.89M-$1.87M-$2.46M-$2.52M
    Last 12 quarters

    Frequently Asked Questions About TIVC

    What is Tivic Health Systems' annual revenue?

    Tivic Health Systems reported revenue of $382.00K for the fiscal year ended Dec 31, 2025.

    How fast is Tivic Health Systems' revenue growing?

    Revenue was down 51.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -40.8%.

    Is Tivic Health Systems profitable?

    No. Tivic Health Systems reported net income of -$8.88M for the fiscal year ended Dec 31, 2025, with a net margin of -2324.1%.

    How much free cash flow does TIVC generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$7.00M minus capital expenditures of $581.00K produced free cash flow of -$7.58M.

    How much debt does Tivic Health Systems have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $6.45M and cash and equivalents of $12.64M.